Rajpaul Attariwala

Rajpaul Attariwala is a declared insider of Algernon Pharmaceuticals Inc., with filings sourced from SEDI. Over a trading history stretching from 17 October 2018 to 23 November 2021, the count stands at 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 21 January 2022, reports a transaction in Algernon Pharmaceuticals Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.